Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


25.03.2019

2 Acta Ophthalmol
1 Am J Ophthalmol
1 Biochem Biophys Res Commun
2 BMJ
3 Circulation
4 Diabet Med
2 Diabetes
17 Diabetes Care
1 Diabetes Educ
2 Diabetes Obes Metab
1 Diabetologia
1 Invest Ophthalmol Vis Sci
1 J Am Coll Cardiol
4 J Clin Endocrinol Metab
1 J Diabetes Complications
1 J Exp Med
2 J Hypertens
1 JAMA
1 Kidney Int
3 Lancet Diabetes Endocrinol
1 Lancet Glob Health
1 Metabolism
1 Pediatr Diabetes
6 PLoS One
1 Proc Natl Acad Sci U S A
2 Retina
1 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. WANG J, Gao X, Liu J, Wang J, et al
    Effect of intravitreal conbercept treatment on the expression of Long Noncoding RNAs and mRNAs in Proliferative Diabetic Retinopathy Patients.
    Acta Ophthalmol. 2019 Mar 22. doi: 10.1111/aos.14083.
    PubMed     Text format     Abstract available

  2. SUN Z, Liu X, Bian C, Wu S, et al
    Sub-Tenon depository triamcinolone and glycaemic management in diabetic patients.
    Acta Ophthalmol. 2019 Mar 22. doi: 10.1111/aos.14100.
    PubMed     Text format    


    Am J Ophthalmol

  3. WUBBEN TJ, Johnson MW
    Anti-VEGF Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.
    Am J Ophthalmol. 2019 Mar 13. pii: S0002-9394(19)30103.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. HE Q, Zhu S, Lin M, Yang Q, et al
    Increased GPR120 level is associated with gestational diabetes mellitus.
    Biochem Biophys Res Commun. 2019 Mar 14. pii: S0006-291X(19)30411.
    PubMed     Text format     Abstract available


    BMJ

  5. WISE J
    The BMJ Awards 2019: Diabetes Team of the Year.
    BMJ. 2019;364:l1232.
    PubMed     Text format    

  6. UEDA P, Svanstrom H, Melbye M, Eliasson B, et al
    Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
    BMJ. 2018;363:k4365.
    PubMed     Text format     Abstract available


    Circulation

  7. KATO ET, Silverman MG, Mosenzon O, Zelniker TA, et al
    Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040130.
    PubMed     Text format     Abstract available

  8. FIGTREE GA, Radholm K, Barrett TD, Perkovic V, et al
    Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040057.
    PubMed     Text format     Abstract available

  9. FURTADO RHM, Bonaca MP, Raz I, Zelniker TA, et al
    Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039996.
    PubMed     Text format     Abstract available


    Diabet Med

  10. TOPOR-MADRY R, Wojtyniak B, Strojek K, Rutkowski D, et al
    Prevalence of diabetes in Poland: a combined analysis of national databases.
    Diabet Med. 2019 Mar 19. doi: 10.1111/dme.13949.
    PubMed     Text format     Abstract available

  11. FAERCH K, Quist JS, Hulman A, Witte DR, et al
    Prospective association between late evening food consumption and risk of prediabetes and diabetes: the Whitehall II cohort study.
    Diabet Med. 2019 Mar 21. doi: 10.1111/dme.13951.
    PubMed     Text format     Abstract available

  12. TAYLOR K, Bain SC
    Foot deformity in a man with Type 2 diabetes.
    Diabet Med. 2019 Mar 21. doi: 10.1111/dme.13950.
    PubMed     Text format     Abstract available

  13. YAN A, Issar T, Tummanapalli SS, Markoulli M, et al
    Relationship between corneal confocal microscopy and markers of peripheral nerve structure and function in Type 2 diabetes.
    Diabet Med. 2019 Mar 21. doi: 10.1111/dme.13952.
    PubMed     Text format     Abstract available


    Diabetes


  14. In This Issue of Diabetes.
    Diabetes. 2019;68:679-680.
    PubMed     Text format    

  15. LI H, O'Meara M, Zhang X, Zhang K, et al
    Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes.
    Diabetes. 2019 Mar 18. pii: db18-0933. doi: 10.2337/db18-0933.
    PubMed     Text format     Abstract available


    Diabetes Care

  16. LATVA-RASKU A, Honka MJ, Kullberg J, Mononen N, et al
    The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
    Diabetes Care. 2019 Mar 18. pii: dc18-1569. doi: 10.2337/dc18-1569.
    PubMed     Text format     Abstract available

  17. ROTBAIN CUROVIC V, Theilade S, Winther SA, Tofte N, et al
    Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Diabetes Care. 2019 Mar 18. pii: dc18-1427. doi: 10.2337/dc18-1427.
    PubMed     Text format     Abstract available

  18. MOLLSTEN A, Toppe C, Eeg-Olofsson K, Lind T, et al
    Sex Differences in Treatment With ACE Inhibitors and Angiotensin Receptor Blockers in Type 1 Diabetes Patients.
    Diabetes Care. 2019 Mar 18. pii: dc18-2542. doi: 10.2337/dc18-2542.
    PubMed     Text format    

  19. PATEL P, Gupta P, Burns A, Mohamed AA, et al
    Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes.
    Diabetes Care. 2019 Mar 18. pii: dc18-1453. doi: 10.2337/dc18-1453.
    PubMed     Text format     Abstract available

  20. DAWED AY, Zhou K, van Leeuwen N, Mahajan A, et al
    Variation in the Plasma Membrane Monoamine Transporter (PMAT, Encoded in SLC29A4) and Organic Cation Transporter 1 (OCT1, Encoded in SLC22A1) and Gastrointestinal Intolerance to Metformin in Type 2 Diabetes: An IMI DIRECT Study.
    Diabetes Care. 2019 Mar 18. pii: dc18-2182. doi: 10.2337/dc18-2182.
    PubMed     Text format     Abstract available

  21. PILEMANN-LYBERG S, Hansen TW, Tofte N, Winther SA, et al
    Uric Acid is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Event and Mortality in Patients With Type 1 Diabetes.
    Diabetes Care. 2019 Mar 18. pii: dc18-2173. doi: 10.2337/dc18-2173.
    PubMed     Text format     Abstract available

  22. CEROSALETTI K, Hao W, Greenbaum CJ
    Erratum. Genetics coming of age in type 1 diabetes. Diabetes Care 2019;42:189-191.
    Diabetes Care. 2019 Mar 18. pii: dc19-er05. doi: 10.2337.
    PubMed     Text format    

  23. SACKS DA, Grant DL, Macias M, Li X, et al
    Erratum. The virtual office visit for women with gestational diabetes mellitus. Diabetes Care 2017;40:e34-e35.
    Diabetes Care. 2019;42:701.
    PubMed     Text format    

  24. BEBU I, Braffett BH, Orchard TJ, Lorenzi GM, et al
    Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    Diabetes Care. 2019 Mar 20. pii: dc18-1613. doi: 10.2337/dc18-1613.
    PubMed     Text format     Abstract available


  25. In This Issue of Diabetes Care.
    Diabetes Care. 2019;42:497-498.
    PubMed     Text format    

  26. LACY ME, Gilsanz P, Karter AJ, Quesenberry CP, et al
    Response to Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339-2345.
    Diabetes Care. 2019;42:e69.
    PubMed     Text format    

  27. MEDRANO-DE-AVILA C, Castillo-Castro C, Lavalle-Gonzalez FJ
    Comment on Lacy et al. Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care 2018;41:2339-2345.
    Diabetes Care. 2019;42:e68.
    PubMed     Text format    

  28. UMPIERREZ GE, Klonoff DC
    Response to Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579-1589.
    Diabetes Care. 2019;42:e66-e67.
    PubMed     Text format    

  29. GRAMMES J, Kuestner E, Heinemann L, Kubiak T, et al
    Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579-1589.
    Diabetes Care. 2019;42:e64-e65.
    PubMed     Text format    

  30. CHENG YJ, Imperatore G, Albright AL, Gregg EW, et al
    Response to Comment on Cheng et al. Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015. Diabetes Care 2018;41:2306-2315.
    Diabetes Care. 2019;42:e63.
    PubMed     Text format    

  31. MANICARDI V, Vicentini M, Ballotari P, Venturelli F, et al
    Comment on Cheng et al. Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015. Diabetes Care 2018;41:2306-2315.
    Diabetes Care. 2019;42:e62.
    PubMed     Text format    

  32. HERMAN WH, Pan Q, Edelstein SL, Mather KJ, et al
    Erratum. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017;40:1668-1677.
    Diabetes Care. 2019;42:701.
    PubMed     Text format    


    Diabetes Educ

  33. MCEWEN MM, Pasvogel A, Murdaugh C
    Effects of a Family-Based Diabetes Intervention on Family Social Capital Outcomes for Mexican American Adults.
    Diabetes Educ. 2019 Mar 21:145721719837899. doi: 10.1177/0145721719837899.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  34. FREEMANTLE N, Jourdan S
    Comment on "A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes".
    Diabetes Obes Metab. 2019 Mar 22. doi: 10.1111/dom.13711.
    PubMed     Text format     Abstract available

  35. HELLER SR, DeVries JH, Wysham C, Hansen CT, et al
    Lower rates of hypoglycaemia in older people with type 2 diabetes when using insulin degludec versus insulin glargine U100: results from SWITCH 2.
    Diabetes Obes Metab. 2019 Mar 20. doi: 10.1111/dom.13708.
    PubMed     Text format     Abstract available


    Diabetologia

  36. DAVIES MJ, D'Alessio DA, Fradkin J, Kernan WN, et al
    Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2019 Mar 21. pii: 10.1007/s00125-019-4845.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  37. LI T, Jia Y, Wang S, Wang A, et al
    Retinal Microvascular Abnormalities in Children with Type 1 Diabetes Mellitus Without Visual Impairment or Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:990-998.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  38. VERMA S, Wanner C, Zwiener I, Ofstad AP, et al
    Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes.
    J Am Coll Cardiol. 2019 Mar 5. pii: S0735-1097(19)33807.
    PubMed     Text format    


    J Clin Endocrinol Metab

  39. AULINAS A, Plessow F, Asanza E, Silva L, et al
    Low Plasma Oxytocin Levels and Increased Psychopathology in Hypopituitary Men with Diabetes Insipidus.
    J Clin Endocrinol Metab. 2019 Mar 18. pii: 5381921. doi: 10.1210/jc.2018-02608.
    PubMed     Text format     Abstract available

  40. THEN C, Then H, Meisinger C, Heier M, et al
    Serum uromodulin is associated with but does not predict type 2 diabetes in elderly KORA F4/FF4 study participants.
    J Clin Endocrinol Metab. 2019 Mar 20. pii: 5393273. doi: 10.1210/jc.2018-02557.
    PubMed     Text format     Abstract available

  41. LI FR, Zhang XR, Zhong WF, Li ZH, et al
    Glycated Hemoglobin and All-cause and Cause-specific Mortality Among Adults With and Without Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393288. doi: 10.1210/jc.2018-02536.
    PubMed     Text format     Abstract available

  42. JIANG J, Cui J, Wang A, Mu Y, et al
    Association Between Age at Natural Menopause and Risk of Type 2 Diabetes in Postmenopausal Obese and Non-Obese Females.
    J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393286. doi: 10.1210/jc.2018-02310.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  43. ROBBINS TD, Lim Choi Keung SN, Sankar S, Randeva H, et al
    Risk factors for readmission of inpatients with diabetes: A systematic review.
    J Diabetes Complications. 2019 Jan 30. pii: S1056-8727(18)31184.
    PubMed     Text format     Abstract available


    J Exp Med

  44. CAROTA IA, Kenig-Kozlovsky Y, Onay T, Scott R, et al
    Targeting VE-PTP phosphatase protects the kidney from diabetic injury.
    J Exp Med. 2019 Mar 18. pii: jem.20180009. doi: 10.1084/jem.20180009.
    PubMed     Text format     Abstract available


    J Hypertens

  45. LOPEZ-JARAMILLO P, Barbosa E, Molina DI, Sanchez R, et al
    Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome.
    J Hypertens. 2019 Mar 14. doi: 10.1097/HJH.0000000000002072.
    PubMed     Text format     Abstract available

  46. SARMA AV, Hotaling JM, de Boer IH, Dunn RL, et al
    Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type I diabetes.
    J Hypertens. 2019 Mar 14. doi: 10.1097/HJH.0000000000001988.
    PubMed     Text format     Abstract available


    JAMA

  47. ZHENG SL, Roddick AJ
    Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
    JAMA. 2019;321:277-287.
    PubMed     Text format     Abstract available


    Kidney Int

  48. XU H, Kuja-Halkola R, Chen X, Magnusson PKE, et al
    Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30047.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol

  49. BOULLE P, Kehlenbrink S, Smith J, Beran D, et al
    Challenges associated with providing diabetes care in humanitarian settings.
    Lancet Diabetes Endocrinol. 2019 Mar 13. pii: S2213-8587(19)30083.
    PubMed     Text format     Abstract available

  50. PERDIGOTO AL, Quandt Z, Anderson M, Herold KC, et al
    Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome.
    Lancet Diabetes Endocrinol. 2019 Mar 15. pii: S2213-8587(19)30072.
    PubMed     Text format    

  51. KEHLENBRINK S, Smith J, Ansbro E, Fuhr DC, et al
    The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries.
    Lancet Diabetes Endocrinol. 2019 Mar 13. pii: S2213-8587(19)30082.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  52. ATRE S
    The burden of diabetes in India.
    Lancet Glob Health. 2019;7:e418.
    PubMed     Text format    


    Metabolism

  53. GILARDI F, Winkler C, Quignodon L, Diserens JG, et al
    Systemic PPARgamma deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility.
    Metabolism. 2019 Mar 13. pii: S0026-0495(19)30051.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  54. ISMAIL HM, Evans-Molina C, DiMeglio LA, Becker DJ, et al
    Associations of HbA1c with the Timing of C-peptide Responses during the Oral Glucose Tolerance Test at the Diagnosis of Type 1 Diabetes.
    Pediatr Diabetes. 2019 Mar 20. doi: 10.1111/pedi.12845.
    PubMed     Text format     Abstract available


    PLoS One

  55. SHIRIN A, Della Rossa F, Klickstein I, Russell J, et al
    Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon.
    PLoS One. 2019;14:e0213665.
    PubMed     Text format     Abstract available

  56. MALEY MJ, Hunt AP, Stewart IB, Faulkner SH, et al
    Passive heating and glycaemic control in non-diabetic and diabetic individuals: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0214223.
    PubMed     Text format     Abstract available

  57. RODRIGUES MRK, Lima SAM, Mazeto GMFDS, Calderon IMP, et al
    Efficacy of vitamin D supplementation in gestational diabetes mellitus: Systematic review and meta-analysis of randomized trials.
    PLoS One. 2019;14:e0213006.
    PubMed     Text format     Abstract available

  58. RHEINBERGER M, Jung B, Segiet T, Nusser J, et al
    Poor risk factor control in outpatients with diabetes mellitus type 2 in Germany: The DIAbetes COhoRtE (DIACORE) study.
    PLoS One. 2019;14:e0213157.
    PubMed     Text format     Abstract available

  59. DE MAN J, Aweko J, Daivadanam M, Alvesson HM, et al
    Diabetes self-management in three different income settings: Cross-learning of barriers and opportunities.
    PLoS One. 2019;14:e0213530.
    PubMed     Text format     Abstract available

  60. BAKKER GJ, Vanbellinghen MC, Scheithauer TP, Verchere CB, et al
    Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls.
    PLoS One. 2019;14:e0213202.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  61. ZHENG X, Narayanan S, Sunkari VG, Eliasson S, et al
    Triggering of a Dll4-Notch1 loop impairs wound healing in diabetes.
    Proc Natl Acad Sci U S A. 2019 Mar 18. pii: 1900351116.
    PubMed     Text format     Abstract available


    Retina

  62. HINKLE JW, Flynn HW, Banta JT
    PATIENTS PRESENTING EMERGENTLY WITH PROLIFERATIVE DIABETIC RETINOPATHY: Follow-up and Factors Associated With Compliance.
    Retina. 2019 Mar 11. doi: 10.1097/IAE.0000000000002481.
    PubMed     Text format     Abstract available

  63. OZSAYGILI C, Duru Z, Cicek A, Ulusoy DM, et al
    THE EFFECT OF AGE ON AFLIBERCEPT (EYLEA) RESPONSE IN DIABETIC MACULAR EDEMA.
    Retina. 2019 Mar 11. doi: 10.1097/IAE.0000000000002504.
    PubMed     Text format     Abstract available


    Stroke

  64. IRVINE H, Male S, Robertson J, Bell C, et al
    Reduced Intracerebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas.
    Stroke. 2019 Mar 18:STROKEAHA118022301. doi: 10.1161/STROKEAHA.118.022301.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: